Abstract
Sodium polystyrene sulfonate (SPSS) is commonly administered for the acute and chronic treatment of hyperkalemia. Its oral intake is complicated by poor compliance due to multifaceted reasons. We therefore analyzed a method of reducing potassium (K) in formula by pretreatment with SPSS. If effective, this would bypass complications of enterally administered SPSS and provide low-K formula. Thirteen formulas and nutritional supplements were pretreated with SPSS to determine if one could bind K and provide formulas with decreased K contents. Using an SPSS concentration of 1 g/l mEq K in the formula, 62±2.6% (P<0.01, mean±SEM) of the K was removed in 30 min, while the sodium (Na) concentration was increased by 234±37% (P<0.01). Analysis suggests that the disproportionate increase in Na is due to exchange for calcium (Ca) and magnesium (Mg), interaction with proteins, and Na suspended with SPSS in the formula. Thus, SPSS pretreatment of formula is an effective method of making low-K formula, but the increase in Na exceeds the K reduction. Attention to possible complications of increased Na intake as well as decreased Ca and Mg intake is warranted.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Steinmetz PR, Kiley JE (1961) Hyperkalemia in renal failure. JAMA 175:689–693
Scherr L, Ogden DA, Mead AW, Spritz N, Rubin AL (1961) Management of hyperkalemia with a cation-exchange resin. N Engl J Med 264: 115–119
Ajioka M, Sugiyama S, Ogawa K, Satake T, Ozawa T (1986) Mechanism of cardiac arrhythmias induced by epinephrine in dogs with hypokalemia. J Am Coll Cardiol 8: 1373–1379
Elkins BR, Watanabe AS (1978) Acute digoxin poisonings: review of therapy.Am J Hosp Pharm 35: 268–277
Greenman L, Peters JH, Mateer FM, Weigand FA, Wilkins D, Tarail R, Rhodes G, Danowski TS (1951) Biochemical changes accompanying the ingestion of a carboxylic cation exchanger in the hydrogen, ammonium, sodium, potassium, or calcium form. J Clin Invest 30: 995–1008
Sherman S, Friedman AP, Berdon WE, Haller JO (1981) Kayexalate. A new cause of neonatal bowel opacification. Pediatr Radiol138: 63–64
Ohlsson A, Hosking M (1987) Complications following oral administration of exchange resins in extremely low-birth-weight infants. Eur J Pediatr 146: 571–574
Lillimoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, Williams GM (1987) Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 101: 267–272
Haupt HM, Hutchins GM (1982) Sodium polystyrene sulfonate pneumonitis. Arch Intern Med 142: 379–381
Wood EG, Bunchman TE, Khurana R, Fleming SS, Lynch RE (1990) Supplemental enteral feedings in children with chronic renal failure (CRF): gastrostomy and nasogastric tube? (abstract). Perit Dial Int 10 [Suppl 1]: 190
Flinn RB, Merrill JP, Weizant WR (1961) Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol. N Engl J Med 264: 111–115
Evans BM, Milne MD, Hughes Jones NC,Yellowlees H (1953) Ion-exchange resins in the treatment of anuria. Lancet II: 791–795
Macaulay D, Watson GH (1954) Tetany following cation-exchange resin therapy. Lancet II: 70–71
Fernandez PC, Kovnat PJ (1972) Metabolic acidosis reversed by the combination of magnesium hydroxide and a cation-exchange resin. N Engl J Med 286: 23–24
Madias NE, Levey AS (1983) Metabolic alkalosis due to absorption of “nonabsorbable” antacids. Am J Med 74: 155–158
Ziessman HA (1976) Alkalosis and seizure due to a cation-exchange resin and magnesium hydroxide. South Med J 69: 497–499
Johnson K, Gardner ME (1978) Kayexalate candy. Am J Hosp Pharmacol 35: 1034–1035
Physicians Desk Reference, 43 rd edn (1989) Medical Economics Company, Oradell, NJ, p 1864
Paulson WD, Maj MC, Bock GH, Nelson AP, Moxey-Mims MM, Crim LM (1989) Hyponatremia in the very young chronic peritoneal dialysis patient. Am J Kidney Dis 14: 196–199
Gonick HC, Maxwell MH, Rubini ME, Kleeman CR (1966) Functional impairment in chronic renal disease: I. studies of sodiumconserving ability. Nephron 3: 137–143
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bunchman, T.E., Wood, E.G., Schenck, M.H. et al. Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake. Pediatr Nephrol 5, 29–32 (1991). https://doi.org/10.1007/BF00852836
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00852836